Global Biologics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 13-Oct-2022
No. of pages: 112
Inquire Before Buying

Report Scope

This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biologics manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Biologics market. Further, it explains the major drivers and regional dynamics of the global Biologics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Eli Lilly & Company

- Samsung Biologics

- F Hoffman La Roche

- Celltrion

- Addgene

- Amgen

- Abbvie Inc.

- Sanofi

- Pfizer Inc.

- Merck & Co. Inc.

- Novo Nordisk A/S

- Johnson & Johnson Services Inc.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.

Biologics Segment by Type

- Monoclonal Antibodies

- Vaccines

- Recombinant Proteins

- Antisense

- RNAi

Biologics Segment by Application

- Infectious Diseases

- Oncology

- Immunology

- Autoimmune Diseases

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Biologics production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Biologics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Biologics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Biologics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Biologics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi and Pfizer Inc., etc.

Global Biologics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Biologics Research Scope
1.2 Market Segment by Type
1.2.1 Global Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Recombinant Proteins
1.2.5 Antisense
1.2.6 RNAi
1.3 Market Segment by Application
1.3.1 Global Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Immunology
1.3.5 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Market Production
2.1 Global Biologics Production Capacity (2017-2028)
2.2 Global Biologics Production by Region: 2017 VS 2021 VS 2028
2.3 Global Biologics Production by Region
2.3.1 Global Biologics Historic Production by Region (2017-2022)
2.3.2 Global Biologics Forecasted Production by Region (2023-2028)
2.3.3 North America
2.3.4 Europe
2.3.5 Japan
2.3.6 China
2.3.7 South Korea
2.3.8 India
2.4 Market Dynamics
2.4.1 Biologics Industry Trends
2.4.2 Biologics Market Drivers
2.4.3 Biologics Market Challenges
2.4.4 Biologics Market Restraints
3 Global Biologics Sales
3.1 Global Biologics Sales Estimates and Forecasts 2017-2028
3.2 Global Biologics Revenue Estimates and Forecasts 2017-2028
3.3 Global Biologics Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Top Biologics Regions by Sales
3.4.1 Global Top Biologics Regions by Sales (2017-2022)
3.4.2 Global Top Biologics Regions by Sales (2023-2028)
3.5 Global Top Biologics Regions by Revenue
3.5.1 Global Top Biologics Regions by Revenue (2017-2022)
3.5.2 Global Top Biologics Regions by Revenue (2023-2028)
3.5.3 North America
3.5.4 Europe
3.5.5 Asia-Pacific
3.5.6 Latin America
3.5.7 Middle East & Africa
4 Competition by Manufacturers
4.1 Global Biologics Production Capacity by Manufacturers
4.2 Global Biologics Sales by Manufacturers
4.2.1 Global Top Biologics Manufacturers by Sales (2017-2022)
4.2.2 Global Top Biologics Manufacturers Market Share by Sales (2017-2022)
4.2.3 Global Top 10 and Top 5 Companies by Biologics Sales in 2021
4.3 Global Biologics Revenue by Manufacturers
4.3.1 Global Top Biologics Manufacturers by Revenue (2017-2022)
4.3.2 Global Top Biologics Manufacturers Market Share by Revenue (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Biologics Revenue in 2021
4.4 Global Biologics Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Biologics Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Biologics Sales by Type
5.1.1 Global Biologics Historical Sales by Type (2017-2022)
5.1.2 Global Biologics Forecasted Sales by Type (2023-2028)
5.1.3 Global Biologics Sales Market Share by Type (2017-2028)
5.2 Global Biologics Revenue by Type
5.2.1 Global Biologics Historical Revenue by Type (2017-2022)
5.2.2 Global Biologics Forecasted Revenue by Type (2023-2028)
5.2.3 Global Biologics Revenue Market Share by Type (2017-2028)
5.3 Global Biologics Price by Type
5.3.1 Global Biologics Price by Type (2017-2022)
5.3.2 Global Biologics Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Biologics Sales by Application
6.1.1 Global Biologics Historical Sales by Application (2017-2022)
6.1.2 Global Biologics Forecasted Sales by Application (2023-2028)
6.1.3 Global Biologics Sales Market Share by Application (2017-2028)
6.2 Global Biologics Revenue by Application
6.2.1 Global Biologics Historical Revenue by Application (2017-2022)
6.2.2 Global Biologics Forecasted Revenue by Application (2023-2028)
6.2.3 Global Biologics Revenue Market Share by Application (2017-2028)
6.3 Global Biologics Price by Application
6.3.1 Global Biologics Price by Application (2017-2022)
6.3.2 Global Biologics Price Forecast by Application (2023-2028)
7 North America
7.1 North America Biologics Sales Breakdown by Company
7.1.1 North America Biologics Sales by Company (2017-2022)
7.1.2 North America Biologics Revenue by Company (2017-2022)
7.2 North America Biologics Market Size by Type
7.2.1 North America Biologics Sales by Type (2017-2028)
7.2.2 North America Biologics Revenue by Type (2017-2028)
7.3 North America Biologics Market Size by Application
7.3.1 North America Biologics Sales by Application (2017-2028)
7.3.2 North America Biologics Revenue by Application (2017-2028)
7.4 North America Biologics Market Size by Country
7.4.1 North America Biologics Sales by Country (2017-2028)
7.4.2 North America Biologics Revenue by Country (2017-2028)
7.4.3 U.S.
7.4.4 Canada
8 Europe
8.1 Europe Biologics Sales Breakdown by Company
8.1.1 Europe Biologics Sales by Company (2017-2022)
8.1.2 Europe Biologics Revenue by Company (2017-2022)
8.2 Europe Biologics Market Size by Type
8.2.1 Europe Biologics Sales by Type (2017-2028)
8.2.2 Europe Biologics Revenue by Type (2017-2028)
8.3 Europe Biologics Market Size by Application
8.3.1 Europe Biologics Sales by Application (2017-2028)
8.3.2 Europe Biologics Revenue by Application (2017-2028)
8.4 Europe Biologics Market Size by Country
8.4.1 Europe Biologics Sales by Country (2017-2028)
8.4.2 Europe Biologics Revenue by Country (2017-2028)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Russia
9 Asia Pacific
9.1 Asia Pacific Biologics Sales Breakdown by Company
9.1.1 Asia Pacific Biologics Sales by Company (2017-2022)
9.1.2 Asia Pacific Biologics Revenue by Company (2017-2022)
9.2 Asia Pacific Biologics Market Size by Type
9.2.1 Asia Pacific Biologics Sales by Type (2017-2028)
9.2.2 Asia Pacific Biologics Revenue by Type (2017-2028)
9.3 Asia Pacific Biologics Market Size by Application
9.3.1 Asia Pacific Biologics Sales by Application (2017-2028)
9.3.2 Asia Pacific Biologics Revenue by Application (2017-2028)
9.4 Asia Pacific Biologics Market Size by Region
9.4.1 Asia Pacific Biologics Sales by Region (2017-2028)
9.4.2 Asia Pacific Biologics Revenue by Region (2017-2028)
9.4.3 China
9.4.4 Japan
9.4.5 South Korea
9.4.6 India
9.4.7 Australia
9.4.8 Taiwan
9.4.9 Indonesia
9.4.10 Thailand
9.4.11 Malaysia
9.4.12 Philippines
10 Latin America
10.1 Latin America Biologics Sales Breakdown by Company
10.1.1 Latin America Biologics Sales by Company (2017-2022)
10.1.2 Latin America Biologics Revenue by Company (2017-2022)
10.2 Latin America Biologics Market Size by Type
10.2.1 Latin America Biologics Sales by Type (2017-2028)
10.2.2 Latin America Biologics Revenue by Type (2017-2028)
10.3 Latin America Biologics Market Size by Application
10.3.1 Latin America Biologics Sales by Application (2017-2028)
10.3.2 Latin America Biologics Revenue by Application (2017-2028)
10.4 Latin America Biologics Market Size by Country
10.4.1 Latin America Biologics Sales by Country (2017-2028)
10.4.2 Latin America Biologics Revenue by Country (2017-2028)
10.4.3 Mexico
10.4.4 Brazil
10.4.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biologics Sales Breakdown by Company
11.1.1 Middle East and Africa Biologics Sales by Company (2017-2022)
11.1.2 Middle East and Africa Biologics Revenue by Company (2017-2022)
11.2 Middle East and Africa Biologics Market Size by Type
11.2.1 Middle East and Africa Biologics Sales by Type (2017-2028)
11.2.2 Middle East and Africa Biologics Revenue by Type (2017-2028)
11.3 Middle East and Africa Biologics Market Size by Application
11.3.1 Middle East and Africa Biologics Sales by Application (2017-2028)
11.3.2 Middle East and Africa Biologics Revenue by Application (2017-2028)
11.4 Middle East and Africa Biologics Market Size by Country
11.4.1 Middle East and Africa Biologics Sales by Country (2017-2028)
11.4.2 Middle East and Africa Biologics Revenue by Country (2017-2028)
11.4.3 Turkey
11.4.4 Saudi Arabia
11.4.5 U.A.E
12 Company Profiles
12.1 Eli Lilly & Company
12.1.1 Eli Lilly & Company Corporation Information
12.1.2 Eli Lilly & Company Overview
12.1.3 Eli Lilly & Company Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.1.4 Eli Lilly & Company Biologics Products and Services
12.1.5 Eli Lilly & Company Biologics SWOT Analysis
12.1.6 Eli Lilly & Company Recent Developments
12.2 Samsung Biologics
12.2.1 Samsung Biologics Corporation Information
12.2.2 Samsung Biologics Overview
12.2.3 Samsung Biologics Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.2.4 Samsung Biologics Biologics Products and Services
12.2.5 Samsung Biologics Biologics SWOT Analysis
12.2.6 Samsung Biologics Recent Developments
12.3 F Hoffman La Roche
12.3.1 F Hoffman La Roche Corporation Information
12.3.2 F Hoffman La Roche Overview
12.3.3 F Hoffman La Roche Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.3.4 F Hoffman La Roche Biologics Products and Services
12.3.5 F Hoffman La Roche Biologics SWOT Analysis
12.3.6 F Hoffman La Roche Recent Developments
12.4 Celltrion
12.4.1 Celltrion Corporation Information
12.4.2 Celltrion Overview
12.4.3 Celltrion Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.4.4 Celltrion Biologics Products and Services
12.4.5 Celltrion Biologics SWOT Analysis
12.4.6 Celltrion Recent Developments
12.5 Addgene
12.5.1 Addgene Corporation Information
12.5.2 Addgene Overview
12.5.3 Addgene Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.5.4 Addgene Biologics Products and Services
12.5.5 Addgene Biologics SWOT Analysis
12.5.6 Addgene Recent Developments
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Overview
12.6.3 Amgen Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.6.4 Amgen Biologics Products and Services
12.6.5 Amgen Biologics SWOT Analysis
12.6.6 Amgen Recent Developments
12.7 Abbvie Inc.
12.7.1 Abbvie Inc. Corporation Information
12.7.2 Abbvie Inc. Overview
12.7.3 Abbvie Inc. Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.7.4 Abbvie Inc. Biologics Products and Services
12.7.5 Abbvie Inc. Biologics SWOT Analysis
12.7.6 Abbvie Inc. Recent Developments
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Overview
12.8.3 Sanofi Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.8.4 Sanofi Biologics Products and Services
12.8.5 Sanofi Biologics SWOT Analysis
12.8.6 Sanofi Recent Developments
12.9 Pfizer Inc.
12.9.1 Pfizer Inc. Corporation Information
12.9.2 Pfizer Inc. Overview
12.9.3 Pfizer Inc. Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.9.4 Pfizer Inc. Biologics Products and Services
12.9.5 Pfizer Inc. Biologics SWOT Analysis
12.9.6 Pfizer Inc. Recent Developments
12.10 Merck & Co. Inc.
12.10.1 Merck & Co. Inc. Corporation Information
12.10.2 Merck & Co. Inc. Overview
12.10.3 Merck & Co. Inc. Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.10.4 Merck & Co. Inc. Biologics Products and Services
12.10.5 Merck & Co. Inc. Biologics SWOT Analysis
12.10.6 Merck & Co. Inc. Recent Developments
12.11 Novo Nordisk A/S
12.11.1 Novo Nordisk A/S Corporation Information
12.11.2 Novo Nordisk A/S Overview
12.11.3 Novo Nordisk A/S Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.11.4 Novo Nordisk A/S Biologics Products and Services
12.11.5 Novo Nordisk A/S Recent Developments
12.12 Johnson & Johnson Services Inc.
12.12.1 Johnson & Johnson Services Inc. Corporation Information
12.12.2 Johnson & Johnson Services Inc. Overview
12.12.3 Johnson & Johnson Services Inc. Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
12.12.4 Johnson & Johnson Services Inc. Biologics Products and Services
12.12.5 Johnson & Johnson Services Inc. Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Biologics Value Chain Analysis
13.2 Biologics Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Biologics Production Mode & Process
13.4 Biologics Sales and Marketing
13.4.1 Biologics Sales Channels
13.4.2 Biologics Distributors
13.5 Biologics Customers
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Vaccines
Table 4. Major Manufacturers of Recombinant Proteins
Table 5. Major Manufacturers of Antisense
Table 6. Major Manufacturers of RNAi
Table 7. Global Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Biologics Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 9. Global Biologics Production by Region (2017-2022) & (K MT)
Table 10. Global Biologics Production Market Share by Region (2017-2022)
Table 11. Global Biologics Production by Region (2023-2028) & (K MT)
Table 12. Global Biologics Production Market Share by Region (2023-2028)
Table 13. Biologics Market Trends
Table 14. Biologics Market Drivers
Table 15. Biologics Market Challenges
Table 16. Biologics Market Restraints
Table 17. Global Biologics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 18. Global Biologics Sales by Region (2017-2022) & (K MT)
Table 19. Global Biologics Sales Market Share by Region (2017-2022)
Table 20. Global Biologics Sales by Region (2023-2028) & (K MT)
Table 21. Global Biologics Sales Market Share by Region (2023-2028)
Table 22. Global Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 23. Global Biologics Revenue Market Share by Region (2017-2022)
Table 24. Global Biologics Revenue by Region (2023-2028) & (US$ Million)
Table 25. Global Biologics Revenue Market Share by Region (2023-2028)
Table 26. Global Biologics Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 27. Global Biologics Capacity Market Share by Manufacturers (2017-2022)
Table 28. Global Biologics Production by Manufacturers (2017-2022) & (K MT)
Table 29. Global Biologics Production Market Share by Manufacturers (2017-2022)
Table 30. Global Biologics Sales by Manufacturers (2017-2022) & (K MT)
Table 31. Global Biologics Sales Share by Manufacturers (2017-2022)
Table 32. Global Biologics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 33. Global Biologics Revenue Share by Manufacturers (2017-2022)
Table 34. Biologics Price by Manufacturers 2017-2022 (USD/MT)
Table 35. Global Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics as of 2021)
Table 37. Biologics Manufacturing Base Distribution and Headquarters
Table 38. Manufacturers Biologics Product Offered
Table 39. Date of Key Manufacturers Enter into Biologics Market
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Biologics Sales by Type (2017-2022) & (K MT)
Table 42. Global Biologics Sales by Type (2023-2028) & (K MT)
Table 43. Global Biologics Sales Share by Type (2017-2022)
Table 44. Global Biologics Sales Share by Type (2023-2028)
Table 45. Global Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 46. Global Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 47. Global Biologics Revenue Share by Type (2017-2022)
Table 48. Global Biologics Revenue Share by Type (2023-2028)
Table 49. Biologics Price by Type (2017-2022) & (USD/MT)
Table 50. Global Biologics Price Forecast by Type (2023-2028) & (USD/MT)
Table 51. Global Biologics Sales by Application (2017-2022) & (K MT)
Table 52. Global Biologics Sales by Application (2023-2028) & (K MT)
Table 53. Global Biologics Sales Share by Application (2017-2022)
Table 54. Global Biologics Sales Share by Application (2023-2028)
Table 55. Global Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 56. Global Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 57. Global Biologics Revenue Share by Application (2017-2022)
Table 58. Global Biologics Revenue Share by Application (2023-2028)
Table 59. Biologics Price by Application (2017-2022) & (USD/MT)
Table 60. Global Biologics Price Forecast by Application (2023-2028) & (USD/MT)
Table 61. North America Biologics Sales by Company (2017-2022) & (K MT)
Table 62. North America Biologics Sales Market Share by Company (2017-2022)
Table 63. North America Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 64. North America Biologics Revenue Market Share by Company (2017-2022)
Table 65. North America Biologics Sales by Type (2017-2022) & (K MT)
Table 66. North America Biologics Sales by Type (2023-2028) & (K MT)
Table 67. North America Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 68. North America Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 69. North America Biologics Sales by Application (2017-2022) & (K MT)
Table 70. North America Biologics Sales by Application (2023-2028) & (K MT)
Table 71. North America Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 72. North America Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 73. North America Biologics Sales by Country (2017-2022) & (K MT)
Table 74. North America Biologics Sales by Country (2023-2028) & (K MT)
Table 75. North America Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 76. North America Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 77. Europe Biologics Sales by Company (2017-2022) & (K MT)
Table 78. Europe Biologics Sales Market Share by Company (2017-2022)
Table 79. Europe Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 80. Europe Biologics Revenue Market Share by Company (2017-2022)
Table 81. Europe Biologics Sales by Type (2017-2022) & (K MT)
Table 82. Europe Biologics Sales by Type (2023-2028) & (K MT)
Table 83. Europe Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 84. Europe Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 85. Europe Biologics Sales by Application (2017-2022) & (K MT)
Table 86. Europe Biologics Sales by Application (2023-2028) & (K MT)
Table 87. Europe Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 88. Europe Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 89. Europe Biologics Sales by Country (2017-2022) & (K MT)
Table 90. Europe Biologics Sales by Country (2023-2028) & (K MT)
Table 91. Europe Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 92. Europe Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 93. Asia Pacific Biologics Sales by Company (2017-2022) & (K MT)
Table 94. Asia Pacific Biologics Sales Market Share by Company (2017-2022)
Table 95. Asia Pacific Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 96. Asia Pacific Biologics Revenue Market Share by Company (2017-2022)
Table 97. Asia Pacific Biologics Sales by Type (2017-2022) & (K MT)
Table 98. Asia Pacific Biologics Sales by Type (2023-2028) & (K MT)
Table 99. Asia Pacific Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 100. Asia Pacific Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 101. Asia Pacific Biologics Sales by Application (2017-2022) & (K MT)
Table 102. Asia Pacific Biologics Sales by Application (2023-2028) & (K MT)
Table 103. Asia Pacific Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 104. Asia Pacific Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 105. Asia Pacific Biologics Sales by Region (2017-2022) & (K MT)
Table 106. Asia Pacific Biologics Sales by Region (2023-2028) & (K MT)
Table 107. Asia Pacific Biologics Revenue by Region (2017-2022) & (US$ Million)
Table 108. Asia Pacific Biologics Revenue by Region (2023-2028) & (US$ Million)
Table 109. Latin America Biologics Sales by Company (2017-2022) & (K MT)
Table 110. Latin America Biologics Sales Market Share by Company (2017-2022)
Table 111. Latin America Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 112. Latin America Biologics Revenue Market Share by Company (2017-2022)
Table 113. Latin America Biologics Sales by Type (2017-2022) & (K MT)
Table 114. Latin America Biologics Sales by Type (2023-2028) & (K MT)
Table 115. Latin America Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 116. Latin America Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 117. Latin America Biologics Sales by Application (2017-2022) & (K MT)
Table 118. Latin America Biologics Sales by Application (2023-2028) & (K MT)
Table 119. Latin America Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 120. Latin America Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 121. Latin America Biologics Sales by Country (2017-2022) & (K MT)
Table 122. Latin America Biologics Sales by Country (2023-2028) & (K MT)
Table 123. Latin America Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 124. Latin America Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Biologics Sales by Company (2017-2022) & (K MT)
Table 126. Middle East and Africa Biologics Sales Market Share by Company (2017-2022)
Table 127. Middle East and Africa Biologics Revenue by Company (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Biologics Revenue Market Share by Company (2017-2022)
Table 129. Middle East and Africa Biologics Sales by Type (2017-2022) & (K MT)
Table 130. Middle East and Africa Biologics Sales by Type (2023-2028) & (K MT)
Table 131. Middle East and Africa Biologics Revenue by Type (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Biologics Revenue by Type (2023-2028) & (US$ Million)
Table 133. Middle East and Africa Biologics Sales by Application (2017-2022) & (K MT)
Table 134. Middle East and Africa Biologics Sales by Application (2023-2028) & (K MT)
Table 135. Middle East and Africa Biologics Revenue by Application (2017-2022) & (US$ Million)
Table 136. Middle East and Africa Biologics Revenue by Application (2023-2028) & (US$ Million)
Table 137. Middle East and Africa Biologics Sales by Country (2017-2022) & (K MT)
Table 138. Middle East and Africa Biologics Sales by Country (2023-2028) & (K MT)
Table 139. Middle East and Africa Biologics Revenue by Country (2017-2022) & (US$ Million)
Table 140. Middle East and Africa Biologics Revenue by Country (2023-2028) & (US$ Million)
Table 141. Eli Lilly & Company Corporation Information
Table 142. Eli Lilly & Company Description and Overview
Table 143. Eli Lilly & Company Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 144. Eli Lilly & Company Biologics Products and Services
Table 145. Eli Lilly & Company Biologics SWOT Analysis
Table 146. Eli Lilly & Company Recent Development
Table 147. Samsung Biologics Corporation Information
Table 148. Samsung Biologics Description and Overview
Table 149. Samsung Biologics Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 150. Samsung Biologics Biologics Products and Services
Table 151. Samsung Biologics Biologics SWOT Analysis
Table 152. Samsung Biologics Recent Development
Table 153. F Hoffman La Roche Corporation Information
Table 154. F Hoffman La Roche Description and Overview
Table 155. F Hoffman La Roche Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 156. F Hoffman La Roche Biologics Products and Services
Table 157. F Hoffman La Roche Biologics SWOT Analysis
Table 158. F Hoffman La Roche Recent Development
Table 159. Celltrion Corporation Information
Table 160. Celltrion Description and Overview
Table 161. Celltrion Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 162. Celltrion Biologics Products and Services
Table 163. Celltrion Biologics SWOT Analysis
Table 164. Celltrion Recent Development
Table 165. Addgene Corporation Information
Table 166. Addgene Description and Overview
Table 167. Addgene Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 168. Addgene Biologics Products and Services
Table 169. Addgene Biologics SWOT Analysis
Table 170. Addgene Recent Development
Table 171. Amgen Corporation Information
Table 172. Amgen Description and Overview
Table 173. Amgen Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 174. Amgen Biologics Products and Services
Table 175. Amgen Biologics SWOT Analysis
Table 176. Amgen Recent Development
Table 177. Abbvie Inc. Corporation Information
Table 178. Abbvie Inc. Description and Overview
Table 179. Abbvie Inc. Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 180. Abbvie Inc. Biologics Products and Services
Table 181. Abbvie Inc. Biologics SWOT Analysis
Table 182. Abbvie Inc. Recent Development
Table 183. Sanofi Corporation Information
Table 184. Sanofi Description and Overview
Table 185. Sanofi Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 186. Sanofi Biologics Products and Services
Table 187. Sanofi Biologics SWOT Analysis
Table 188. Sanofi Recent Development
Table 189. Pfizer Inc. Corporation Information
Table 190. Pfizer Inc. Description and Overview
Table 191. Pfizer Inc. Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 192. Pfizer Inc. Biologics Products and Services
Table 193. Pfizer Inc. Biologics SWOT Analysis
Table 194. Pfizer Inc. Recent Development
Table 195. Merck & Co. Inc. Corporation Information
Table 196. Merck & Co. Inc. Description and Overview
Table 197. Merck & Co. Inc. Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 198. Merck & Co. Inc. Biologics Products and Services
Table 199. Merck & Co. Inc. Biologics SWOT Analysis
Table 200. Merck & Co. Inc. Recent Development
Table 201. Novo Nordisk A/S Corporation Information
Table 202. Novo Nordisk A/S Description and Overview
Table 203. Novo Nordisk A/S Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 204. Novo Nordisk A/S Biologics Products and Services
Table 205. Novo Nordisk A/S Recent Development
Table 206. Johnson & Johnson Services Inc. Corporation Information
Table 207. Johnson & Johnson Services Inc. Description and Overview
Table 208. Johnson & Johnson Services Inc. Biologics Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 209. Johnson & Johnson Services Inc. Biologics Products and Services
Table 210. Johnson & Johnson Services Inc. Recent Development
Table 211. Key Raw Materials Lists
Table 212. Raw Materials Key Suppliers Lists
Table 213. Biologics Distributors List
Table 214. Biologics Customers List
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Product Picture
Figure 2. Global Biologics Market Share by Type in 2021 & 2028
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Recombinant Proteins Product Picture
Figure 6. Antisense Product Picture
Figure 7. RNAi Product Picture
Figure 8. Global Biologics Market Share by Application in 2021 & 2028
Figure 9. Infectious Diseases
Figure 10. Oncology
Figure 11. Immunology
Figure 12. Autoimmune Diseases
Figure 13. Biologics Report Years Considered
Figure 14. Global Biologics Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 15. Global Biologics Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Biologics Production Market Share by Region (2017-2022)
Figure 17. Global Biologics Production Market Share by Region (2023-2028)
Figure 18. Biologics Production Growth Rate in North America (2017-2028) & (K MT)
Figure 19. Biologics Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 20. Biologics Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 21. Biologics Production Growth Rate in China (2017-2028) & (K MT)
Figure 22. Biologics Production Growth Rate in South Korea (2017-2028) & (K MT)
Figure 23. Biologics Production Growth Rate in India (2017-2028) & (K MT)
Figure 24. Global Biologics Sales 2017-2028 (K MT)
Figure 25. Global Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 26. Global Biologics Revenue 2017-2028 (US$ Million)
Figure 27. Global Biologics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 28. Global Biologics Sales Market Share by Region (2017-2022)
Figure 29. Global Biologics Sales Market Share by Region (2023-2028)
Figure 30. North America Biologics Sales YoY (2017-2028) & (K MT)
Figure 31. North America Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Europe Biologics Sales YoY (2017-2028) & (K MT)
Figure 33. Europe Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Biologics Sales YoY (2017-2028) & (K MT)
Figure 35. Asia-Pacific Biologics Revenue YoY (2017-2028) & (US$ Million)
Figure 36. Latin America Bio
  • Global Nucleotide Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Nucleotide Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Bioburden Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......
  • Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......
  • Global Interferon Market Research Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Interferon Professional Survey Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......
  • Global Nucleotide Market Insights, Forecast to 2029
    Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89
    Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......
  • 2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel
    Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs